Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
“The art now is to match the intensity of treatment to both global cardiovascular risk and the patient’s blood pressure, rather than chasing a number at all costs.” – Dr. Carolyn Lam, National Heart Center of Singapore
Cardiology March 27th 2026
Heart
Studies on fluid restriction in patients with HF are scarce, and most of the available studies are at high risk of bias. Although power is lacking, there is no evidence indicating that fluid restriction affects mortality or HF hospitalizations, but there is a signal of harm in terms of thirst distress.
Cardiology March 25th 2026
Conexiant
The researchers discovered that findings among older adults reinforced the guideline shift toward personalized, risk-based care.
EP Lab Digest
There needs to be increased awareness among primary care doctors and general cardiologists that patients with persistent symptomatic AF are sometimes better served by promptly scheduling a cardioversion while waiting for an appointment with an electrophysiologist.
Physician’s Weekly
The study highlights the importance of integrated preventive measures, especially for adults with traditional risk factors for CVD. Vaccines may play an important role in preventing the risk of CVD.
“Patients hospitalized for HFrEF in US clinical practice are at very high risk of poor clinical outcomes, even when prescribed quadruple medical therapy.” — Dr. Stephen J. Greene, Duke Clinical Research Institute
Cardiology February 23rd 2026